Multi-Active Moisturizing Cream for Radiation Dermatitis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for radiation dermatitis are haphazard and lack standardized formulations to prevent or treat the condition effectively, leading to skin damage, infections, and potential interruptions in radiation therapy, which can adversely affect treatment efficacy.
Innovation Solution
A topical cream containing a moisturizer base with ceramides, emollients, humectants, and occlusives, combined with corticosteroids, silymarin, and epigallocatechin-3-gallate (EGCG), applied before and during radiation therapy to maintain skin barrier function and reduce dermatitis severity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If radiation therapy is administered to treat cancer, then cancer destruction is achieved, but radiation dermatitis and skin damage occur as collateral damage
Solution Approach 1:
The patent introduces a topical cream formulation as an intermediary substance that mediates between radiation therapy and skin tissue. The cream contains protective agents (vitamin E, aloe vera, hyaluronic acid, ceramides) that act as intermediaries to reduce direct radiation damage to skin cells while allowing cancer-targeting radiation to pass through and reach the tumor.
Solution Approach 2:
The patent converts harmful radiation effects into beneficial outcomes by using radiation-induced oxidative stress as a signal to activate protective mechanisms. The topical cream contains antioxidants that scavenge harmful free radicals generated by radiation, converting the harmful oxidative stress into a protective response that reduces skin damage while maintaining radiation's anticancer efficacy.
2Object-affected harmful factors
If standardized prophylactic treatment is implemented, then radiation dermatitis severity is reduced, but treatment complexity increases
Solution Approach 1:
The patent merges multiple protective functions into a single topical cream formulation. Instead of requiring separate applications of different protective agents, the formulation combines antioxidants (vitamin E, aloe vera), hydrating agents (hyaluronic acid), and barrier-repair components (ceramides) into one unified product that can be applied once daily, simplifying the treatment protocol while providing comprehensive skin protection.
Solution Approach 2:
The topical cream formulation is designed with multi-functionality to address multiple aspects of radiation dermatitis prevention simultaneously. The same formulation provides antioxidant protection, hydration, barrier repair, and anti-inflammatory effects, making it a universal solution that can be used for all patients receiving radiation therapy regardless of their specific risk factors or treatment parameters.
3Reliability
If skin barrier function is maintained during radiation therapy, then radiation dermatitis is prevented, but skin permeability to radiation may be affected
Solution Approach 1:
The patent applies local quality by using a topical formulation that acts locally on the skin surface and superficial layers without interfering with deeper tissue radiation exposure. The protective agents are concentrated at the skin barrier level where they can protect against radiation damage while allowing radiation photons to penetrate through to the tumor at deeper tissue levels, creating different functional zones within the treated area.
Data Source
AI summary
A topical formulation is provided for treating systems of radiation treatments that includes a moisturizer base, and a plurality of active ingredients that include a corticosteroid, silymarin, and epigallocatechin-3-gallate (EGCG).